fda ruling semaglutide no more compounding Despite ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market Semaglutide: Compounding pharmacies to end – FDA approves Ozempic® (semaglutide) as

Immunol Today

Published Evidence vs Community Protocols Where each AOD-9604 cycle claim comes from Claim AOD-9604 was studied for 12 weeks Published human support Yes, using oral doses Community support Often used as a community timeline How it should be described Published duration, but not a proven SubQ cycle Claim AOD-9604 was studied for 24 weeks Published human support Yes, using oral tablets Community support Sometimes used to justify longer plans How it should be described Published oral trial

TRIUMPH-4 was the first to report positive results in December 2025

The committee recommended against inclusion in the 503A Bulks Regulation, effectively suspending compounding availability while evaluation continues

While existing reviews primarily focus on carnitine-lipid metabolism relationships, comprehensive analyses detailing its molecular roles across the MASLD spectrum remain limited

They act like a natural hormone in the body that helps control blood sugar and appetitetwo key factors in managing diabetes and supporting weight loss